Benchmark Rating and PT Updates 7/29

Benchmark made a number of rating and price target updates in a research report published today. CryoLife CRY had its rating upgraded from Hold to Buy. Its price target was maintained at $6.50. On Thursday, CRY lost 1.99% of its value to finish the day at $5.42. Expedia EXPE had its rating reiterated at Hold. At the same time, its price target was raised from $34 to $36. On Thursday, EXPE lost 2.59% of its value to finish the day at $28.99. Its shares rebounded in today's pre-market trading, rising 5.45% to stand around $30.57. Meredith MDP had its rating reiterated at Hold. At the same time, its price target was reduced from $35 to $33. On Thursday, MDP lost 0.41% of its value to finish the day at $29.01. RTI Biologics RTIX had its rating upgraded from Hold to Buy. At the same time, its price target was raised from $3 to $4. On Thursday, RTIX added 8.72% to its value to end the day at $3.24. STEC STEC had its rating downgraded from Buy to Hold. At the moment, the rating agency does not have a price target placed on the company's stock. On Thursday, STEC added 1.18% to its value to finish the day at $16.70. Its shares are having a disastrous session in today's pre-market trading, slumping 35.69% to stand around $10.74. True Religion Apparel TRLG had its rating reiterated at Buy. At the same time, its price target was raised from $34 to $38. On Thursday, TRLG added 4.58% to its value to finish the day at $29.71. Its shares continued to climb in today's pre-market trading, rising 8.01% to stand around $32.09. Valassis Communications VCI had its rating reiterated at Buy. At the same time, its price target was raised from $38 to $37. On Thursday, VCI lost 6.88% of its value to finish the day at $27.75.